SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Jemal A, Siegel R, Ward E et al. Cancer statistics, 2006. CA Cancer J Clin 2006; 56: 10630
  • 2
    Tannenbaum M. Adenoid cystic or ‘salivary gland’ carcinomas of prostate. Urology 1975; 6: 2389
  • 3
    Iczkowski KA, Ferguson KL, Grier DD et al. Adenoid cystic/basal cell carcinoma of the prostate: clinicopathologic findings in 19 cases. Am J Surg Pathol 2003; 27: 15239
  • 4
    Frankel K, Craig JR. Adenoid cystic carcinoma of the prostate. Report of a case. Am J Clin Pathol 1974; 62: 63945
  • 5
    Hasan N, Dodd S. Basal cell carcinoma of the prostate. Histopathology 1996; 28: 571
  • 6
    McKenney JK, Amin MB, Srigley JR et al. Basal cell proliferations of the prostate other than usual basal cell hyperplasia: a clinicopathologic study of 23 cases, including four carcinomas, with a proposed classification. Am J Surg Pathol 2004; 28: 128998
  • 7
    Young RH, Frierson HF Jr, Mills SE, Kaiser JS, Talbot WH, Bhan AK. Adenoid cystic-like tumor of the prostate gland. A report of two cases and review of the literature on ‘adenoid cystic carcinoma’ of the prostate. Am J Clin Pathol 1988; 89: 4956
  • 8
    Devaraj LT, Bostwick DG. Atypical basal cell hyperplasia of the prostate. Immunophenotypic profile and proposed classification of basal cell proliferations. Am J Surg Pathol 1993; 17: 64559
  • 9
    Grignon DJ, Ro JY, Ordonez NG, Ayala AG, Cleary KR. Basal cell hyperplasia, adenoid basal cell tumor, and adenoid cystic carcinoma of the prostate gland: an immunohistochemical study. Hum Pathol 1988; 19: 142533
  • 10
    Denholm SW, Webb JN, Howard GC, Chisholm GD. Basaloid carcinoma of the prostate gland: histogenesis and review of the literature. Histopathology 1992; 20: 1515
  • 11
    Randolph TL, Amin MB, Ro JY, Ayala AG. Histologic variants of adenocarcinoma and other carcinomas of prostate: pathologic criteria and clinical significance. Mod Pathol 1997; 10: 61229
  • 12
    Cohen RJ, Goldberg RD, Verhaart MJ, Cohen M. Adenoid cyst-like carcinoma of the prostate gland. Arch Pathol Lab Med 1993; 117: 799801
  • 13
    Schmid HP, Semjonow A, Eltze E, Wortler K, Hertle L. Late recurrence of adenoid cystic carcinoma of the prostate. Scand J Urol Nephrol 2002; 36: 1589
  • 14
    Minei S, Hachiya T, Ishida H, Okada K. Adenoid cystic carcinoma of the prostate: a case report with immunohistochemical and in situ hybridization staining for prostate-specific antigen. Int J Urol 2001; 8: S414
  • 15
    Terris MK. The appearance of adenoid cystic carcinoma of the prostate on transrectal ultrasonography. BJU Int 1999; 83: 8756
  • 16
    Palazzo C, Valentini M, Capuya G, Costa M. [Adenoid cystic carcinoma of the prostate]. Arch Esp Urol 2004; 57: 11335
  • 17
    Fayyad LM, Al-Jader KM, Al-Hawwari BA. Asynchronous adenoid cystic carcinoma of the prostate and transitional cell carcinoma of the urinary bladder. Saudi Med J 2006; 27: 10602
  • 18
    Partin AW, Rodriguez R. The molecular biology, endocrinology, and physiology of the prostate and seminal vesicles. In WalshPC, RetikA, Darracott VaughanE, WeinAJ eds, Campbell’s Urology, 8th edn. Philadelphia: WB Saunders, 2002: 12405
  • 19
    Robinson EJ, Neal DE, Collins AT. Basal cells are progenitors of luminal cells in primary cultures of differentiating human prostatic epithelium. Prostate 1998; 37: 14960
  • 20
    Wojno KJ, Epstein JI. The utility of basal cell-specific anti-cytokeratin antibody (34βE12) in the diagnosis of prostate cancer. A review of 228 cases. Am J Surg Pathol 1995; 19: 25160
  • 21
    Epstein JI, Armas OA. Atypical basal cell hyperplasia of the prostate. Am J Surg Pathol 1992; 16: 120514
  • 22
    Montironi R, Mazzucchelli R, Stramazzotti D, Scarpelli M, Lopez Beltran A, Bostwick DG. Basal cell hyperplasia and basal cell carcinoma of the prostate: a comprehensive review and discussion of a case with c-erbB-2 expression. J Clin Pathol 2005; 58: 2906
  • 23
    Yang XJ, McEntee M, Epstein JI. Distinction of basaloid carcinoma of the prostate from benign basal cell lesions by using immunohistochemistry for bcl-2 and Ki-67. Hum Pathol 1998; 29: 144750
  • 24
    Hosler GA, Epstein JI. Basal cell hyperplasia: an unusual diagnostic dilemma on prostate needle biopsies. Hum Pathol 2005; 36: 4805
  • 25
    Tulunay O, Orhan D, Gogus C, Culha E, Muftuoglu YZ. Adenoid-basal cell tumor of the prostate gland. A case report: histomorphologic and immunohistochemical features. Int Urol Nephrol 2004; 36: 513
  • 26
    Ahn SK, Kim K, Choi IJ, Lee JM. Adenoid cystic carcinoma of the prostate gland – pathological review with a case report. Yonsei Med J 1991; 32: 748
  • 27
    Thackray A, Lucas R. Tumors of major salivary glands. In Atlas of Pathology, Sect IV (Fasc 10). Washington DC: Armed Forces Institute of Pathology, 1974: 919
  • 28
    Mastropasqua MG, Pruneri G, Renne G, De Cobelli O, Viale G. Basaloid cell carcinoma of the prostate. Virchows Arch 2003; 443: 78791
  • 29
    Tan P, Billis A. Basal cell carcinoma. In EbleJN, SauterG, EpsteinJ, SesterhennI eds, World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs. Lyon, France: IARC Press, 2004, 206 pp.
  • 30
    Chan SS, Walters MN. Adenoid cystic carcinoma of prostate. Report of a case. Pathology 1984; 16: 3378
  • 31
    Gilmour AM, Bell TJ. Adenoid cystic carcinoma of the prostate. Br J Urol 1986; 58: 1056
  • 32
    Kramer SA, Bredael JJ, Krueger RP. Adenoid cystic carcinoma of the prostate: report of a case. J Urol 1978; 120: 3834
  • 33
    Kuhajda FP, Mann RB. Adenoid cystic carcinoma of the prostate. A case report with immunoperoxidase staining for prostate-specific acid phosphatase and prostate-specific antigen. Am J Clin Pathol 1984; 81: 25760
  • 34
    Parada DD, Lopez CA, Moreira O. Basaloid carcinoma of the prostate gland. An unusual finding. Arch Esp Urol 2004; 57: 5738
  • 35
    Shah RB, Kunju LP, Shen R, LeBlanc M, Zhou M, Rubin MA. Usefulness of basal cell cocktail (34βE12 + p63) in the diagnosis of atypical prostate glandular proliferations. Am J Clin Pathol 2004; 122: 51723
  • 36
    Iczkowski KA, Pantazis C, Collins J. The loss of expression of CD44 standard and variant isoforms is related to prostate carcinoma development and tumour progression. J Urol Pathol 1997; 6: 11929